healthprotocol.wiki

medication-dasatinib

Outcomes

01
oncology-overall-response-rate-percent
1 evidence row
- verstovsek_2008_cohort_phase-ii-study-of-dasatinib-in-philadelphia-chromosome-negative-acute-and-chronic-myeloid-diseases-including-systemic-mastocytosis